Mandate

Vinge advises Bregal Unternehmerkapital on its acquisition of Iptor

January 07, 2020 M&A

Vinge has advised Bregal Unternehmerkapital on its acquisition of Iptor from Marlin Equity Partners.

Iptor is a global leader in enterprise resource planning, supply chain management, planning and logistics software and services. Serving 1,250 customers in more than 40 countries, Iptor provides fully integrated enterprise solutions, with highly adaptable and robust software backed by world-class support from distribution and supply chain experts.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Carl Sander, Martin Cronsioe, Fredric Reissmüller, Viktor Lennartsson and Karl Klackenberg (M&A), Albert Wållgren and Ludvig Wettergren (Banking and Finance), Jolene Reimerson, Jasmin Draszka, Mika Jordan, Fredrika Hjelmberg, Lisa Hörnqvist and Sofia Landolsi (Commercial Agreements), Jakob Kraus (IP), Lisa Ullman and Sophia Holm (Employment), Karolina Cohrs (Real Estate) and VDR assistants Viktoria Owetz and Christoffer Widström.

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025